| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |